MicroDose receives milestone payment under Novartis pact
The milestone payment follows the successful incorporation of MicroDose’s DPI technology into a Novartis platform pulmonary device. In addition to the upfront payment received, MicroDose is entitled to
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.